Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1585) 1585
Publication (124) 124
Book Review (31) 31
Dissertation (11) 11
Conference Proceeding (5) 5
Book Chapter (4) 4
Newsletter (3) 3
Magazine Article (2) 2
Government Document (1) 1
Paper (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
gatifloxacin (1362) 1362
humans (621) 621
fluoroquinolones (500) 500
moxifloxacin (433) 433
pharmacology & pharmacy (426) 426
index medicus (396) 396
levofloxacin (390) 390
ciprofloxacin (336) 336
male (293) 293
microbial sensitivity tests (284) 284
female (261) 261
microbiology (259) 259
infectious diseases (221) 221
animals (195) 195
ophthalmology (171) 171
adult (169) 169
middle aged (168) 168
anti-infective agents - pharmacology (165) 165
fluoroquinolones - pharmacology (160) 160
antibiotics (158) 158
aged (150) 150
pharmacokinetics (144) 144
quinolones (139) 139
anti-bacterial agents - pharmacology (138) 138
fluoroquinolones - therapeutic use (130) 130
ofloxacin (124) 124
resistance (120) 120
fluoroquinolones - administration & dosage (116) 116
fluoroquinolone (110) 110
anti-bacterial agents - therapeutic use (109) 109
tuberculosis (103) 103
analysis (97) 97
treatment outcome (97) 97
fluoroquinolones - adverse effects (96) 96
anti-infective agents - therapeutic use (94) 94
in-vitro (92) 92
anti-infective agents - administration & dosage (91) 91
chemistry, analytical (88) 88
medicine & public health (84) 84
aged, 80 and over (83) 83
susceptibility (82) 82
anti-bacterial agents - administration & dosage (79) 79
drug resistance, bacterial (76) 76
rabbits (76) 76
streptococcus pneumoniae - drug effects (73) 73
streptococcus-pneumoniae (73) 73
administration, oral (72) 72
fluoroquinolones - pharmacokinetics (72) 72
internal medicine (71) 71
pharmacology/toxicology (71) 71
ofloxacin - pharmacology (70) 70
anti-infective agents - pharmacokinetics (69) 69
endophthalmitis (69) 69
penetration (69) 69
quinolines - pharmacology (69) 69
bacterial infections and mycoses (68) 68
anti-bacterial agents - adverse effects (67) 67
adolescent (66) 66
antibacterial agents (66) 66
mycobacterium-tuberculosis (65) 65
therapy (65) 65
aza compounds - pharmacology (64) 64
dose-response relationship, drug (64) 64
drug resistance (62) 62
ciprofloxacin - pharmacology (59) 59
performance liquid-chromatography (58) 58
bacteria (57) 57
drugs (57) 57
eye infections, bacterial - microbiology (57) 57
hypoglycemia (57) 57
infections (57) 57
prospective studies (57) 57
anti-bacterial agents - pharmacokinetics (56) 56
human plasma (56) 56
anti-infective agents - adverse effects (55) 55
aza compounds - pharmacokinetics (55) 55
quinolines - pharmacokinetics (55) 55
chemistry, multidisciplinary (53) 53
gatifloxacin 0.3-percent (53) 53
research (53) 53
fluoroquinolones - chemistry (52) 52
mycobacterium tuberculosis - drug effects (52) 52
safety (52) 52
administration, topical (51) 51
chromatography, high pressure liquid (51) 51
cataract-surgery (50) 50
chemistry, medicinal (50) 50
drug therapy (50) 50
drug therapy, combination (50) 50
keratitis (50) 50
medicine, general & internal (50) 50
quinolines - therapeutic use (50) 50
quinolone antibacterial agents (50) 50
trovafloxacin (50) 50
antimicrobial agents (49) 49
health aspects (49) 49
mice (49) 49
aza compounds - therapeutic use (48) 48
pulmonary tuberculosis (48) 48
quinolone (48) 48
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1558) 1558
Chinese (12) 12
Spanish (10) 10
French (9) 9
Japanese (7) 7
Korean (7) 7
Portuguese (3) 3
German (2) 2
Turkish (2) 2
Croatian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Once-daily oral gatifloxacin versus oral levofloxacin in treatment of uncomplicated skin and soft tissue infections: double-blind, multicenter, randomized study
by Tarshis, GA and Miskin, BM and Jones, TM and Champlin, J and Wingert, KJ and Breen, JD and Brown, MJ
Antimicrobial Agents & Chemotherapy, ISSN 0066-4804, 08/2001, Volume 45, Issue 8, pp. 2358 - 2362
This was a double-blind, multicenter study in which 410 adults ( greater than or equal to 18 years of age) with uncomplicated skin and soft tissue infections... 
Gatifloxacin
Journal Article
Details down arrow
2. Full Text Gatifloxacin, an advanced 8-methoxy fluoroquinolone
by Fish, D.N and Fish, D.N and North, D.S and North, D.S
Pharmacotherapy, ISSN 0277-0008, 2001, Volume 21, Issue 1, pp. 35 - 59
Gatifloxacin is a new 8-methoxy-fluoroquinolone antibiotic approved for use in the United States in December 1999. It has a broad spectrum of activity, with... 
STREPTOCOCCUS-PNEUMONIAE | 6-FLUORO-8-METHOXY QUINOLONE | ANTIBACTERIAL ACTIVITY | PSEUDOMONAS-AERUGINOSA | SIDE-EFFECT RELATIONSHIPS | DNA GYRASE | LOWER RESPIRATORY-TRACT | PHARMACOLOGY & PHARMACY | RESISTANT STAPHYLOCOCCUS-AUREUS | COMPARATIVE IN-VITRO | ANTIMICROBIAL ACTIVITY | Fluoroquinolones | Animals | Anti-Infective Agents - administration & dosage | Anti-Infective Agents - adverse effects | Bacterial Infections - drug therapy | Anti-Infective Agents - chemistry | Anti-Infective Agents - pharmacokinetics | Anti-Infective Agents - pharmacology | Humans | Bacteria - drug effects | Anti-Infective Agents - therapeutic use | Pharmacokinetics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Concentrations of gatifloxacin in plasma and urine and penetration into prostatic and seminal fluid, ejaculate, and sperm cells after single oral administrations of 400 milligrams to volunteers
by Naber, CK and Steghafner, M and Kinzig-Schippers, M and Sauber, Ch and Sorgel, F and Stahlberg, H-J and Naber, KG
Antimicrobial Agents & Chemotherapy, ISSN 0066-4804, 01/2001, Volume 45, Issue 1, pp. 293 - 297
Gatifloxacin (GTX), a new fluoroquinolone with extended antibacterial activity, is an interesting candidate for the treatment of chronic bacterial prostatitis... 
Gatifloxacin
Journal Article
Details down arrow
4. Full Text Design and characterization of multifaceted lyophilized liposomal wafers with promising wound healing potential
by Avachat, Amelia M and Takudage, Pooja J
Journal of Liposome Research, ISSN 0898-2104, 07/2018, Volume 28, Issue 3, pp. 193 - 208
Various dressings are available to heal chronic wounds which many times fail to achieve the expected results. To overcome some of their drawbacks, formulation... 
gatifloxacin (GTX) | Chitosan | lyophilized liposomal wafers | chronic wound | liposomal gel | GATIFLOXACIN | ALGINATE | BIOCHEMISTRY & MOLECULAR BIOLOGY | FORMULATION | 0.3-PERCENT | PHARMACOLOGY & PHARMACY | DRESSINGS | PERMEATION | Viscosity | Rats, Wistar | Freeze Drying | Male | Cholesterol - chemistry | Particle Size | Gatifloxacin - pharmacology | Lipids - chemistry | Liposomes - chemistry | Animals | Chitosan - chemistry | Anti-Bacterial Agents - chemistry | Surface Properties | Drug Liberation | Female | Anti-Bacterial Agents - pharmacology | Mechanical Phenomena | Gatifloxacin - chemistry | Wound Healing - drug effects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Analysis of the drug therapy of gatifloxacin and levofloxacin in the treatment of acute bacterial conjunctivitis
by Xu, J and Feng, J
PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, ISSN 1011-601X, 07/2018, Volume 31, Issue 4, pp. 1757 - 1760
Acute bacterial conjunctivitis is an acute conjunctivitis that is frequently transmitted in summer and autumn. It is a common and frequently occurring disease... 
CELL LUNG-CANCER | drug sensitivity | antimicrobial spectrum | Gatifloxacin | PHARMACOLOGY & PHARMACY | acute bacterial conjunctivitis | ESOPHAGEAL CANCER | CARCINOMA | Gatifloxacin - administration & dosage | Double-Blind Method | Ophthalmic Solutions - therapeutic use | Humans | Middle Aged | Gatifloxacin - adverse effects | Male | Gatifloxacin - therapeutic use | Microbial Sensitivity Tests | Young Adult | Conjunctivitis, Bacterial - drug therapy | Adolescent | Levofloxacin - therapeutic use | Adult | Female | Aged | Levofloxacin - administration & dosage | Levofloxacin - adverse effects | Levofloxacin | Bacteria | Conjunctivitis | Ophthalmology | Drug therapy | Analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Which fluoroquinolones are suitable for the treatment of urinary tract infections
by Naber, KG
International Journal of Antimicrobial Agents, ISSN 0924-8579, 04/2001, Volume 17, Issue 4, pp. 331 - 341
A number of fluoroquinolone agents are now available for clinical use and even more under development. Whether these compounds are equally effective and thus... 
Gatifloxacin
Journal Article
Details down arrow
7. Development and physical characterization of a periodontal bioadhesive gel of gatifloxacin
by Kassab, Hanan Jalal and Thomas, Lena Murad and Jabir, Saba Abdulhadi
International Journal of Applied Pharmaceutics, ISSN 0975-7058, 2017, Volume 9, Issue 3, pp. 31 - 36
Periodontal gel | Gatifloxacin | Mucoadhesive
Journal Article
Details down arrow
8. Activity of gatifloxacin and ciprofloxacin in combination with other antimicrobial agents
by Gradelski, E and Kolek, B and Bonner, DP and Valera, L and Minassian, B and Fung-Tomc, J
International Journal of Antimicrobial Agents, ISSN 0924-8579, 02/2001, Volume 17, Issue 2, pp. 103 - 107
The influence of non-quinolone antimicrobial agents on the antibacterial activities of gatifloxacin and ciprofloxacin was determined using chequerboard,... 
gatifloxacin
Journal Article
Details down arrow
9. Susceptibility of bacterial isolates to gatifloxacin and ciprofloxacin from clinical trials 1997-1998
by Huczko, E and Conetta, B and Bonner, D and Valera, L and Stickle, T and Macko, A and Fung-Tomc, J
International Journal of Antimicrobial Agents, ISSN 0924-8579, 12/2000, Volume 16, Issue 4, pp. 401 - 405
MICs of gatifloxacin and ciprofloxacin against 3482 pre-treatment, clinical trial isolates collected during 1997-1998 are reported. These data suggested that... 
gatifloxacin
Journal Article
Details down arrow
10. Full Text A Four-Month Gatifloxacin-Containing Regimen for Treating Tuberculosis
by Merle, CS and Fielding, K and Sow, OB and Gninafon, M and Lo, MB and Mthiyane, T and Odhiambo, J and Amukoye, E and Bah, B and Kassa, F
The New England Journal of Medicine, ISSN 0028-4793, 04/2015, Volume 372, Issue 17, pp. 1677 - 1677
A Four-Month Gatifloxacin-Containing Regimen for Treating Tuberculosis Original Article, N Engl J Med 2014;371:1588-1598. In Table 2 (page 1594), the values... 
MEDICINE, GENERAL & INTERNAL | Gatifloxacin | Tuberculosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Gatifloxacin is superior to levofloxacin and moxifloxacin in shorter treatment regimens for multidrug-resistant TB
by Van Deun, A and Decroo, T and Kuaban, C and Noeske, J and Piubello, A and Aung, K J M and Rieder, H L
The International Journal of Tuberculosis and Lung Disease, ISSN 1027-3719, 09/2019, Volume 23, Issue 9, p. 965
SETTING: Data were collected from patients starting one of the shorter treatment regimens (STRs) for multidrug-resistant tuberculosis (MDR-TB) in Bangladesh,... 
Short tandem repeats | Levofloxacin | Tuberculosis | Gatifloxacin | Moxifloxacin | Drug resistance | Reintroduction
Journal Article
Details down arrow
12. First derivative synchronous fluorescence spectroscopy for the determination of Gatifloxacin in presence of its oxidative degradation product: Application to pharmaceutical preparation
by Salama, Fathy M M and Attia, Khalid A M and Said, Ragab A M and El-Attar, Abdul-Aziz M M
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 01/2019, Volume 206, p. 302
A highly accurate and precise spectrofluorimetric method was established for quantitation of Gatifloxacin in pure material, pharmaceutical formulations and in... 
Microbial Sensitivity Tests | Gatifloxacin - analysis | Spectrometry, Fluorescence - methods | Gatifloxacin - pharmacology | Limit of Detection | Oxidation-Reduction | Tablets | Drug Stability | Bacteria - drug effects | Linear Models | Gatifloxacin - chemistry
Journal Article
Details down arrow
13. Full Text Ciprofloxacin-isatin-1H-1,2,3-triazole Hybrids: Design, Synthesis, and in vitro Anti-tubercular Activity against M.tuberculosis
by Xu, Z and Lv, ZS and Song, XF and Qiang, M
JOURNAL OF HETEROCYCLIC CHEMISTRY, ISSN 0022-152X, 01/2018, Volume 55, Issue 1, pp. 97 - 102
A new set of ciprofloxacin (CPFX)-isatin-1H-1,2,3-triazole hybrids 6a-l with greater lipophilicity compared with the parent CPFX was designed, synthesized, and... 
GATIFLOXACIN | ETHYLENE ISATIN DERIVATIVES | CHEMISTRY, ORGANIC | ANTIMYCOBACTERIAL EVALUATION
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents
by Hoellman, DB and Lin, G and Jacobs, MR and Appelbaum, PC
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 05/1999, Volume 43, Issue 5, pp. 645 - 649
An agar dilution MIC method was used to test the activity of gatifloxacin, a new broad-spectrum fluoroquinolone, compared with ciprofloxacin, levofloxacin,... 
gatifloxacin
Journal Article
Details down arrow
15. Full Text Ciprofloxacin–Isatin Hybrids and Their Antimycobacterial Activities
by Xu, Zhi and Zhao, Shi‐Jia and Deng, Jia‐Lun and Wang, Qin and Lv, Zao‐Sheng
Journal of Heterocyclic Chemistry, ISSN 0022-152X, 01/2019, Volume 56, Issue 1, pp. 319 - 324
A series of diethylene glycol tethered ciprofloxacin–isatin hybrids 5a–j were designed, synthesized, and evaluated for their in vitro antimycobacterial... 
CHEMISTRY, ORGANIC | GATIFLOXACIN | DESIGN | DERIVATIVES
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Usefulness of simultaneous and sequential monitoring of glucose level and electrocardiogram in monkeys treated with gatifloxacin under conscious and nonrestricted conditions
by YOSHIMATSU, Yu and ISHIZAKA, Tomomichi and CHIBA, Katsuyoshi and MORI, Kazuhiko
Experimental Animals, ISSN 1341-1357, 2018
Drug-induced cardiac electrophysiological abnormalities accompanied by hypoglycemia or hyperglycemia increase the risk for life-threatening arrhythmia. To... 
gatifloxacin | monkeys | QT prolongation | hypoglycemia | free-moving
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text The cardiovascular toxicity induced by high doses of gatifloxacin and ciprofloxacin in zebrafish
by Shen, Rong and Yu, Ran and Yu, Yichang and Lan, Rong and Yuan, Ze and Xia, Zhining
Environmental Pollution, ISSN 0269-7491, 11/2019, Volume 254, Issue Pt B, p. 112861
As a new type of pollutant, fluoroquinolones (FQs) antibiotics are ubiquitous in environment and have some threat to human health and ecological environment.... 
Zebrafish | Ciprofloxacin | Gatifloxacin | Cardiovascular toxicity | Environmental risk
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18. Full Text Gatifloxacin‐1,2,3‐triazole‐isatin hybrids and their antimycobacterial activities
by Ding, Zhen and Hou, Panfei and Liu, Bi
Archiv der Pharmazie, ISSN 0365-6233, 10/2019, Volume 352, Issue 10, pp. e1900135 - n/a
A series of gatifloxacin‐1,2,3‐triazole‐isatin hybrids 8a–l were designed, synthesized, and screened for their in vitro antimycobacterial activity as well as... 
gatifloxacin | antimycobacterial | 1,2,3‐triazole | antitubercular | isatin | multidrug resistant
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
19. In-vitro activities of gatifloxacin, sparfloxacin and trovafloxacin against 103 strains of Legionella spp
by Croco, MAT and Biedenbach, DJ and Pfaller, MA and Doern, GV and Jones, RN
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 11/1998, Volume 42, Issue 5, pp. 672 - 673
The present study was undertaken to evaluate the in-vitro activity of the novel quinolone, gatifloxacin (formerly CG5501, AM-1155), against 103 isolates of... 
gatifloxacin
Journal Article
Details down arrow
20. Full Text Oral and i.v. formulations of gatifloxacin cleared for US market
by Miller, J L
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, ISSN 1079-2082, 02/2000, Volume 57, Issue 3, pp. 204 - 204
PHARMACOLOGY & PHARMACY | Fluoroquinolones | Drug Labeling | Anti-Infective Agents - administration & dosage | Injections, Intravenous | Administration, Oral | Gatifloxacin | United States | Anti-Infective Agents - chemistry | Humans | Drug Approval
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.